BioActor news All Articles News Webinars BioActor and UM establish a Public Private Partnership to study the benefits of Aronia on cognitionNews Naxus® positive clinical results on its contribution towards an effective vaccination in elderly individualsNews The effects of berry anthocyanins on cognition – New publicationNews Collaboration with Prof Venema shows short term effects of MicrobiomeX® in TIM-2 modelNews 6 Best Ingredients For Brain HealthArticles The health benefits of Aronia Berry: why should you consume this superfruit?Articles Partnership between BioActor and Wageningen University to integrate microbiota and immunity into a miniaturized assayNews WEBINAR – Learn about VitalityWebinars New Open Label Study: BrainBerry® improves cognitive parameters in young, healthy e-gamersNews WATTS’UP® – New Study on Peak Force & Anaerobic Performance Published in Peer-reviewed JournalNews BioActor and Biovital extend their partnership to include the distribution of BRAINBERRY® for the compounding pharmacy market in BrazilNews Active Pharmaceutica appointed as Exclusive Distributor of WATTS’UP® for the compounding pharmacy market in BrazilNews Clinical and pre-clinical data on MicrobiomeX® now published in a peer-reviewed journalNews New Actiful® clinical study on physical fitness and mental wellness in active seniorsNews New Product Launch | Brainberry®News Yakult Korea launched a new synbiotic food product ‘MPRO3’with MicrobiomeX® for intestinal health.News WATTS’UP® receives an approved health claim from Health CanadaNews New Open label Study MicrobiomeX® on intestinal health & well-being in triathlon athletes.News A new study with Olecol® on attenuating sugar digestion and absorption has been published in a peer reviewed scientific journal.News INFLAVOBIOTICS Project from BioActor receives grant from CROSSROADS-ProgrammeNews BioActor receives grant from LIOF and Provincie Limburg for the BrainWave projectNews WATTS’UP® clinical results on the improvement of exercise performance in trained athletes have been published in a peer reviewed scientific journalNews BioActor and Topsport Limburg start collaboration on new sports nutrition product lineNews Cordiart® and Bonolive®obtained registration by the Malaysian National Pharmaceutical Regulatory AgencyNews Clinical results published in a leading nutrition journal provide novel evidence supporting the beneficial effect of consumption of citrus flavanones on postprandial endothelial function.News Naxus®| Results of a randomized controlled trial on reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects published in high impact journalNews BioActor’s Research Director Sam Possemiers Introduces Cordiart® at MIS 2014: 21-22 May, Quimper- FranceNews New Bonolive® clinical results published in peer reviewed journal. New product launches in USA and GermanyNews Bonolive® clinical results will be presented during the 13th European Congress on Osteoporosis and Osteoarthritis in RomeNews BioActor receives EUROSTARS grant for the FlaMeS project “Flavonoids and metabolic syndrome”News BioActor acquires Arabinoxylan-assets from DF3-WITAXOS and obtains positive EFSA opinion for its Arabinoxylan ingredientNews BioActor closes Series A financing round to fund growth strategyNews Approved new clinical trial with Bonolive®News BioActor and Jaeckering sign Joint Development & Marketing Agreement on wheat extractNews BioActor and INRA sign License Agreement on Olive Polyphenols and Bone HealthNews
